All true, lucky they have their other products to get revenue from, but as we have seen before from other biotech trials like mesoblast, if the trials show good results, the price will shoot the lights out, further trials will keep pushing, regardless off sales. Unlike MSB MXC has a product they sell in paralell, they are de-risked from having everything riding on this.
All true, lucky they have their other products to get revenue...
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.015(3.80%) |
Mkt cap ! $17.20M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 37.5¢ | $3.279K | 8.598K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1707 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 718 | 2 |
View Market Depth
| Last trade - 15.45pm 03/05/2024 (20 minute delay) ? |
| RGT (ASX) Chart |